Press releases
-
22-11-2011 We Care for Health – Our Passion, Your Investment
In Q3 2011, the Pelion Healthcare Group (in the process of changing its name from Polska Grupa Farmaceutyczna) maintained strong sales growth across all the operating segments, while significantly improving its quarterly financial performance. At the end of Q3 2011, the Group's revenue stood at PLN 1.628m, having increased by 12% year on year, while its consolidated net profit was PLN 14.5m, up by 173% quarter on quarter and by 5% year on year. Moreover, the Group recorded a significant increase in EBITDA, of 45% and 15%, respectively. Throughout 2011, the Group has expanded considerably faster than the pharmaceutical market. The Management Board has upheld its 2011 forecast, which assumes a double-digit growth of net profit in 2011. The Group continued to focus on building the value of the retail brand. The results of that effort included strengthening of the market position of the Apteki Dbam o Zdrowie retail network and a steadily growing number of loyal patients. The Group continues to intensively develop its dedicated programmes for senior citizens, under which patients are offered attractively priced prescription drugs through the Apteki Dbam o Zdrowie network. In October alone, the number of registered patients rose threefold, to over 100 thousand.
-
06-09-2011 Investing in the future
In H1 2011, Polska Grupa Farmaceutyczna recorded improved sales across all segments of its operations. Sales revenue reached PLN 3.2bn, having increased by 15.7% year on year. This means that PGF's sales grew faster than the whole market by about a dozen percentage points. In Q2 alone, the PGF Group's sales revenue reached PLN 1.6bn, having advanced by 11.1% year on year. Moreover, H1 2011 brought a nearly two-fold increase in the number of patients benefiting from the attractively priced prescription drugs available through the Dbam o Zdrowie pharmacies under the 60+ and Senior programmes.
-
20-05-2011 Good performance in Q1 2011
In Q1 2011, Polska Grupa Farmaceutyczna posted consolidated net profit of PLN 17m on revenues of nearly PLN 1.7bn, reporting growth across all operating segments. Earnings per share improved by 23.9%, while net margin stayed flat at 1%, that is below the European average for the sector. The Company upholds its 2011 guidance, which assumes a double-digit growth of net profit over PLN 70.7m posted in 2010.
-
04-03-2011 Polska Grupa Farmaceutyczna Reports Strong Performance for 2010
Polska Grupa Farmaceutyczna, which in 2010 celebrated its 20th anniversary, ended the year with sales revenue of PLN 5,802m and consolidated net profit of PLN 71m (1.2% of revenue). Going forward, the Group plans to further enhance its financial performance, while continuing and developing its innovative projects and programmes.
-
17-11-2010 Twenty Years of Experience – Solid Foundations For Further Growth
Polska Grupa Farmaceutyczna, which celebrates its 20th anniversary this year, closed the third quarter of 2010 with consolidated net profit of PLN 13.8m and sales revenue of PLN 1.5bn. For the nine months of 2010, the Group’s net profit reached PLN 47.1m, while its sales revenue came to PLN 4.3bn. Accordingly, PGF reaffirms its earlier forecasts of year-end results. Recent developments include the start of work on the expansion of the Company’s warehouse in Łódź, as well as the implementation, across the I Care for My Health network of pharmacies, of a scheme designed to help patients buy medicines at affordable prices.
-
06-09-2010 Growth Reported Across All Operating Segments
In the first six months of 2010, Polska Grupa Farmaceutyczna delivered the best financial results ever recorded in its twenty-year-long operating history. We turned in net profit of PLN 33m and revenue of PLN 2,803bn, and we continued to grow in all operating segments: wholesale of pharmaceuticals to pharmacies and hospitals, retail sale, and services provided to manufacturers. Excellent financial performance reported in the first six months of the year provides a solid foundation for further growth and offers even greater confidence that the full-year targets will be achieved.
-
24-05-2010 PGF Emerges from Crisis with Renewed Strength
In Q1 2010, Polska Grupa Farmaceutyczna posted PLN 14m in consolidated net profit and PLN 1,395m in sales revenue. Despite a very modest growth of the Polish pharmacy market in the first three months of 2010 (which barely exceeded 1%), PGF confirms its previously announced 2010 sales guidance in excess of PLN 6bn.
-
08-03-2010 Results of PGF Group after the fourth quarter 2009
Polska Grupa Farmaceutyczna ended the year 2009 with consolidated net profit of PLN 65.5m and sales revenue of PLN 5.4bn. In the final months of 2009, the PGF Group was mostly focused on effective implementation of new ventures and its innovative strategy.
-
18-11-2009 Results of PGF Group after the third quarter 2009
Polska Grupa Farmaceutyczna ended the third quarter of 2009 with consolidated net profit of PLN 16.5m and sales revenue in excess of PLN 1.3bn. The Groups also commenced the implementation of new, innovative ventures.
-
02-09-2009 Good Performance in Difficult Times
Polska Grupa Farmaceutyczna ended the first half of 2009 with consolidated net profit of PLN 22.2m and revenue in excess of PLN 2.6bn. In a period difficult for the economy, the Group managed to improve its performance thanks to the savings programme implemented earlier and the reduction of investments.